CSL | Competitive Intelligence Profile
CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including treatments for haemophilia...
CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including treatments for haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis, and nephrology. Established in 1916, CSL operates through its businesses CSL Behring, CSL Seqirus, and CSL Vifor, providing products to patients in over 100 countries and employing 32,000 people. The company is known for its focus on complex biologicals, vaccines, plasma and plasma-derived therapeutics, and biotechnology.
🛍️ CSL Product and Pricing Intelligence →
📅 CSL Event Participations →
⚖️ CSL Regulatory Intelligence →
👔 CSL Management and Leadership Team →
⚔️ CSL Alternatives and Competitors →
💼 CSL Hiring and Layoffs →
🤝 CSL Partnerships, Clients and Vendors →
📈 CSL Financial Performance, Fundraising, M&A →
🛍️ CSL Product and Pricing Intelligence
Leverage product insights to define key product development milestones, guide go-to-market planning, build a robust product-market fit matrix, and perform in-depth SWOT analyses.
Harness pricing intelligence to support strategic pricing decisions, conduct competitive pricing analysis, and craft effective differential pricing strategies.
- CSL Seqirus started shipping its 2025/26 flu vaccines to U.S. healthcare providers, offering the only differentiated portfolio for all eligible age groups.
- CSL announced a new monoclonal antibody treatment on July 9.
- CSL launched FluForum, a new portal dedicated to influenza, featuring five thematic areas including clinical, prevention, social, multimedia, and education.
📅 CSL Event Participations
Stay updated on where your competitors are showing up—industry conferences, webinars, podcasts, and speaking engagements—to gauge their messaging, target audiences, and strategic focus. Discover how they’re positioning themselves in the market, what narratives they’re pushing, and which partnerships they’re cultivating. Use this intelligence to refine your own positioning, identify missed opportunities, and stay top-of-mind in your industry.
- CSL hosts a networking event with Jumar Bioincubator on September 17, 2025 at its new $750m Global Headquarters in Melbourne.
- CSL showcased its newly approved product #Andembry at #HAEA2025 in Baltimore with interactive activities like hoops and caricatures, collaborating with Gabriele Design.
- CSL hosted a symposium at the HTAi annual meeting in Buenos Aires, discussing the need for resilient supply and better policies for plasma-derived medicinal products.
⚖️ CSL Regulatory Intelligence
Monitor critical regulatory events—such as issued or revoked licenses, lawsuits, investigations, and court rulings—to understand the compliance posture and legal exposure of your rivals. Spot early warning signs of operational risk, delays, or reputational damage, and use these insights to fine-tune your market strategy, mitigate your own risk, or capitalize on competitor setbacks.
- CSL may face significant impact from proposed US tariffs as it uses American blood products, some processed in Australia before export back to the US.
👔 CSL Management and Leadership Team
Understand who’s steering your competitors by tracking changes in their management and leadership teams. Gain insights into strategic direction, leadership style, and organizational priorities based on executive backgrounds and hiring trends. Use this knowledge to anticipate competitive moves, tailor your sales or partnership approach, and benchmark against industry leaders.
-
Chief Financial Officer
[email protected] -
Executive Director, Genetic Medicine Platform[email protected]
-
Executive Vice President & Chief Commercial Officer[email protected]
-
CFO Brazil
-
CEO & Managing Director
-
Managing Director[email protected]
-
Executive Director, R&D Global Platform Leader, Plasma Product Development[email protected]
-
Managing Director[email protected]
-
Board Executive Director
-
Non Executive Director[email protected]
-
Managing Director[email protected]
⚔️ CSL Alternatives and Competitors
Identify the competitors of your competitors to uncover indirect threats, emerging disruptors, and untapped opportunities. Understand the broader competitive ecosystem, spot white space in the market, and gain strategic context that helps you position more effectively. These insights sharpen your market intelligence and reveal angles others often overlook.
- AbbVie |
- GSK |
- Merck |
- Bristol Myers Squibb |
- AstraZeneca |
- Baxter International |
- Grifols |
- Takeda |
- ADMA Biologics |
- Kedrion |
- iBus Networks |
- Actility |
- IOT Communications |
- Sonic Healthcare |
- Taisho Pharmaceutical Holdings |
- China Biologic Products |
- Biotest |
- Armajaro Holdings |
- Recruitment Agency |
- Citibase Limited |
- KKR |
- MI |
- Novavax |
- Taibang Biological Group |
- Roche |
- Teva Pharmaceutical Industries |
- Octapharma |
- Abeona |
- Emergent |
- Rockwell Medical |
- Antares Pharma |
- AMAG |
- Assertio |
- Shire
💼 CSL Hiring and Layoffs
Track key workforce changes—new hires, leadership shifts, and layoffs—to spot strategic organizational moves. Identify rising competitors, uncover shifts in company direction, and seize opportunities to attract top talent or engage new decision-makers. Use these insights to refine your recruitment strategy and build stronger business relationships.
- Senthil K. joins CSL as Senior Director in the United States, previously Director, Enterprise Architect at Fresenius Medical Care.
- Lilian (Petito) Pititto joins CSL as Market Access Associate Director in Brazil, previously Sr. Strategic Market Access & Pricing Manager at Novo Nordisk.
- Bjarte Furnes, Head of Project Toxicology at CSL in Switzerland, left to join Newleos Therapeutics as Sr Director Toxicology.
🤝 CSL Partnerships, Clients and Vendors
Monitor new partnerships, client wins, and vendor relationships to understand where your competitors are gaining traction. Spot emerging alliances, evaluate ecosystem shifts, and identify potential partners or prospects early. These insights help you refine your sales strategy, anticipate market movements, and stay one step ahead in a dynamic competitive landscape.
- CSL's Seqirus Germany entered the German travel vaccine market in an exclusive partnership with Valneva, focusing initially on the Chikungunya virus and planning to expand to cholera and Japanese encephalitis vaccines from 2026.
- CSL Seqirus partners with Wake Tech for a new biomechatronics apprenticeship program.
📈 CSL Financial Performance, Fundraising, M&A
Track competitors’ financial performance, fundraising rounds, and M&A activity to assess their growth trajectory and strategic focus. Uncover signals of expansion, market entry, or consolidation, and benchmark your position accordingly. Use these insights to inform investor conversations, identify acquisition opportunities, and fine-tune your competitive strategy.
- CSL shares dropped as Morgans cut its target price but called the stock 'materially undervalued', with analyst Derek Jellinek citing a 35% upside potential.
- CSL reported a sales revenue of approximately ***** billion U.S. dollars in the financial year 2023.
- CSL prepares to slash R&D as it deals with upcoming Trump tariffs, focusing on significant internal changes.
People also viewed
- Resene |
- OBI |
- Decathlon |
- Lindt |
- iDeal |
- SBB |
- LMT |
- OC VISION |
- If Insurance |
- Aeschbach |
- DICOTA
Ready to outsmart the competition? RivalSense cuts through the clutter of generic tools like Google Alerts, delivering laser-focused competitive intelligence without the noise. Track competitors’ every move—website changes, product updates, social media buzz, news mentions, and regulatory shifts—all in one sleek platform. Uncover pricing strategies, decode market trends, and gain actionable insights to fuel your business strategy. No more guesswork. Just power.
Join thousands of forward-thinking teams who trust RivalSense to automate their competitive monitoring and turn data into domination. Start your FREE trial today—no credit card needed—and see why staying ahead has never been this easy. Your competitors won’t know what hit them.
Outthink. Outpace. Outperform. #RivalSense